Back
SpareBank 1 SMN Vs. Monopar Therapeutics Industry Stock Comparison
Sell
31
SRMGF
SpareBank 1 SMN
Last Price:
12.43
Seasonality Move:
0%
Buy
65
MNPR
Monopar Therapeutics
Last Price:
34.14
Seasonality Move:
7.43%
Sell
31
SpareBank 1 SMN (SRMGF)
is a Sell
Is SpareBank 1 SMN a Buy, Sell or Hold?
- The current SpareBank 1 SMN [SRMGF] share price is $12.43. The Score for SRMGF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- SRMGF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $32.66. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRMGF Stock Price Chart
What is SpareBank 1 SMN's stock price today?
-
The SpareBank 1 SMN share price today is $12.43
The current trend is relatively stagnant and SRMGF is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $32.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRMGF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.43 - 12.43) | Sell |
Bollinger Bands (100): | (12.69 - 16.73) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.46 | Buy |
Relative Strength Index (14 RSI): | 93.57 | Buy |
Chaikin Money Flow: | 12436621 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.85 - 11.69) | Buy |
Bollinger Bands (100): | (0.99 - 7.11) | Buy |
SRMGF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.43 | Sell |
20-day SMA: | 12.43 | Sell |
50-day SMA: | 12.92 | Sell |
200-day SMA: | 15.6 | Sell |
8-day EMA: | 12.43 | Sell |
20-day EMA: | 12.48 | Sell |
50-day EMA: | 13.13 | Sell |
200-day EMA: | 15.04 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.64 | Buy |
20-day SMA: | 6.69 | Buy |
50-day SMA: | 4.51 | Buy |
200-day SMA: | 3.61 | Buy |
8-day EMA: | 11.25 | Buy |
20-day EMA: | 7.63 | Buy |
50-day EMA: | 5.48 | Buy |
200-day EMA: | 4.09 | Buy |
SpareBank 1 SMN Earnings Growth & SRMGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.
SpareBank 1 SMN Technical Analysis
Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |